COVID-19 infection and vaccination in patients with skeletal muscle channelopathies.

ABSTRACT:

Introduction/aims

Although we have gained insight into coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus 2 since the beginning of the pandemic, our understanding of the consequences for patients with neuromuscular disorders is evolving. In this study we aimed to study the impact of COVID-19 and COVID-19 vaccination on skeletal muscle channelopathies.

Methods

We conducted a survey of patients with genetically confirmed skeletal muscle channelopathies seen at the UK Nationally Commissioned Channelopathy Service.

Results

Thirty-eight patient responses were received. Six patients had COVID-19 infection leading to exacerbation of their underlying muscle channelopathy. No major complications were reported. Thirty-six patients had re

SUBMITTER: Vivekanandam V 

PROVIDER: S-EPMC9537950 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature